Robert L. Bratzler serves as Executive at Coley Pharmaceutical Group, Inc., where they oversee executive responsibilities. Since joining the company, Robert L. Bratzler has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 4, 2008 involved transacting 308,697 shares valued at $0.
Robert L. Bratzler currently holds 0 shares of Coley Pharmaceutical Group, Inc. (COLY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert L. Bratzler has been a net neutral trader of COLY stock. They have purchased $0 and sold $0 worth of shares.
Robert L. Bratzler's most recent insider trade was on Jan 4, 2008, when they sold 308,697 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |